Fiduciary Alliance’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$637K Buy
7,509
+910
+14% +$91.4K 0.04% 337
2025
Q4
$674K Sell
6,599
-490
-7% -$43.8K 0.04% 295
2025
Q3
$443K Sell
7,089
-680
-9% -$37K 0.03% 360
2025
Q2
$404K Sell
7,769
-2,515
-24% -$112K 0.03% 347
2025
Q1
$438K Sell
10,284
-1,595
-13% -$68.8K 0.04% 274
2024
Q4
$363K Buy
11,879
+836
+8% +$23.5K 0.04% 272
2024
Q3
$253K Hold
11,043
0.03% 220
2024
Q2
$319K Buy
+11,043
New +$257K 0.05% 159

Other funds holding GH

Fiduciary Alliance's GH Position: Q1 2026 in Review

Fiduciary Alliance increased its Guardant Health (GH) stake by 14% in Q1 2026, buying an estimated $91.4K and bringing the position to 7,509 shares worth $637K. The position accounts for 0.04% of the portfolio, ranked #337.

Fiduciary Alliance first reported a position in GH in Q2 2024 and has held it in 8 quarters since. The position peaked at $674K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Fiduciary Alliance held 7,509 shares of Guardant Health worth $637K as of Q1 2026.
  • Fiduciary Alliance bought 910 Guardant Health shares in Q1 2026, an estimated $91.4K.
  • Guardant Health made up 0.04% of Fiduciary Alliance's portfolio in Q1 2026, its #337 holding.
  • Fiduciary Alliance first reported a position in Guardant Health in Q2 2024 and has held it in 8 quarters since.
  • Fiduciary Alliance's Guardant Health position peaked at $674K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Fiduciary Alliance's 13F filing for Q1 2026, filed 20 Apr 2026.